NR

Nagi Reddy Seelam

Active Director Managing Director DIN 01764665
DIN 01764665 First appointment Apr 2003 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Apr 2003
Shareholding value •••• Premium profile

About Nagi Reddy Seelam

Data last updated:

Nagi Reddy Seelam has 23 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Concord Drugs Limited and Orange Bio Pharmaceuticals Private Limited. Formerly with 5 companies, such as Seelam Laboratories Private Limited and Neutron Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹61.87 Cr; the largest is Concord Drugs Limited at ₹45.26 Cr (FY 2025).

DIN 01764665
Primary Designation Managing Director
First Appointment 04 Apr 2003
Oldest Company Age 31 yrs
Largest company Concord Drugs Limited · ₹45.26 Cr (FY 2025)
Combined revenue ₹61.87 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Concord Drugs Limited L24230TG1995PLC020093
Managing Director04 Apr 20031995₹45.26 Cr (FY 2025)Active
Cortex Laboratories Private Limited U24230TG1995PTC020588
Director22 Jun 20241995₹16.61 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Seelam Laboratories Private Limited U24232TG2010PTC068611
Director28 May 20102010₹9.84 Cr (FY 2024)Active
Neutron Laboratories Private Limited U24297TG2010PTC068547
Additional Director05 Jan 20172010–Active
Director06 Nov 20102009–Active
Proton Remedies Private Limited U24232TG2008PTC061073
Director17 Sep 20082008₹10.29 Cr (FY 2025)Active
Director20 May 20102010–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Concord Drugs Limited
Orange Bio Pharmaceuticals Private Limited
Cortex Laboratories Private Limited
Seelam Laboratories Private Limited
Premium access

Shareholding and investment profile for Nagi Reddy Seelam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagi Reddy Seelam

Nagi Reddy Seelam has 23 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Concord Drugs Limited and Orange Bio Pharmaceuticals Private Limited. Formerly with 5 companies, such as Seelam Laboratories Private Limited and Neutron Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹61.87 Cr; the largest is Concord Drugs Limited at ₹45.26 Cr (FY 2025).

Nagi Reddy Seelam is associated with 2 companies as Managing Director and Director, including Concord Drugs Limited (₹45.26 Cr), Cortex Laboratories Private Limited (₹16.61 Cr).

Nagi Reddy Seelam has expertise in General Business.

Nagi Reddy Seelam has 23 years in corporate governance.

By reported revenue, the largest current company of Nagi Reddy Seelam is Concord Drugs Limited, with revenue of ₹45.26 Cr (FY 2025).

The 2 current companies of Nagi Reddy Seelam that report revenue have a combined latest revenue of ₹61.87 Cr.

Nagi Reddy Seelam currently holds positions at 2 companies: Concord Drugs Limited (₹45.26 Cr), Cortex Laboratories Private Limited (₹16.61 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available